Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs10783124
rs10783124
G 0.700 GeneticVariation GWASCAT Genetic risk score raises the risk of incidence of chronic kidney disease in Korean general population-based cohort. 30955190

2019

dbSNP: rs10794720
rs10794720
T 0.700 GeneticVariation GWASCAT New loci associated with kidney function and chronic kidney disease. 20383146

2010

dbSNP: rs10808565
rs10808565
0.010 GeneticVariation BEFREE We further identified a common haplotype containing the C allele at rs10808565 and the A allele at rs13447075 that was associated with ESRD (P = 0.003). 17881614

2007

dbSNP: rs10887800
rs10887800
0.010 GeneticVariation BEFREE Distribution of genotypes and frequencies of alleles of rs10887800 polymorphism were compared in the following subgroups of patients: ESRD HY + (n = 278) and ESRD HY - (n = 143). 21617193

2012

dbSNP: rs10906850
rs10906850
C 0.700 GeneticVariation GWASCAT Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study. 31178898

2019

dbSNP: rs10951982
rs10951982
0.010 GeneticVariation BEFREE The other three SNPs (rs10951982, rs6954996, and rs9374), in all comparison models, were not associated with ESRD risk (P > 0.05). 26841219

2016

dbSNP: rs11011653
rs11011653
0.700 GeneticVariation GWASCAT Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium. 26420894

2016

dbSNP: rs11089781
rs11089781
0.010 GeneticVariation BEFREE Stratifying by APOL1 risk genotype (recessive) and adjusting for African ancestry identified a significant additive association between rs11089781 and ESKD in each stratum and in a meta-analysis [meta-analysis P  =  0.0070; odds ratio (OR) = 1.29]; ORs were consistent across APOL1 risk strata. 28339911

2018

dbSNP: rs11089788
rs11089788
0.010 GeneticVariation BEFREE Based on a large Chinese IgAN cohort, we found an association between rs11089788 and prognosis of IgAN, adding to the mounting evidence of MYH9 as an important gene in IgAN to ESRD. 21245129

2011

dbSNP: rs11123169
rs11123169
C 0.700 GeneticVariation GWASCAT A catalog of genetic loci associated with kidney function from analyses of a million individuals. 31152163

2019

dbSNP: rs11128347
rs11128347
0.700 GeneticVariation GWASCAT Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes. 21546767

2011

dbSNP: rs112201728
rs112201728
T 0.700 GeneticVariation GWASCAT Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms. 29545352

2018

dbSNP: rs112329286
rs112329286
TTTTA 0.700 GeneticVariation GWASCAT Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms. 29545352

2018

dbSNP: rs112407915
rs112407915
A 0.700 GeneticVariation GWASCAT Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study. 31178898

2019

dbSNP: rs11320420
rs11320420
G 0.700 GeneticVariation GWASCAT Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms. 29545352

2018

dbSNP: rs114425659
rs114425659
A 0.700 GeneticVariation GWASCAT Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study. 31178898

2019

dbSNP: rs1145077
rs1145077
T 0.700 GeneticVariation GWASCAT A catalog of genetic loci associated with kidney function from analyses of a million individuals. 31152163

2019

dbSNP: rs115007604
rs115007604
A 0.700 GeneticVariation GWASCAT Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study. 31178898

2019

dbSNP: rs115489112
rs115489112
0.010 GeneticVariation BEFREE Two additional variants (H800R and Y1174H) were nominally associated with protection from end stage renal disease (P=0.036; odds ratio, 0.44; P=0.0084; odds ratio, 0.040, respectively) in the locus-wide single-variant association tests. 24948143

2014

dbSNP: rs11571317
rs11571317
0.010 GeneticVariation BEFREE The present study was designed to investigate the impact of CTLA-4+49 A>G (rs231775), -318 C>T (rs5742909), -658 C>T (rs11571317), -1147 C>T (rs16840252), -1661 A>G (rs4553808), +6230 A>G (rs3087243) SNPs, and microsatellite (AT)n repeat polymorphism among end-stage renal disease (ESRD), acute allograft rejection (AR), and delayed graft function (DGF) cases. 24313821

2014

dbSNP: rs115747230
rs115747230
C 0.700 GeneticVariation GWASCAT Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study. 31178898

2019

dbSNP: rs11614913
rs11614913
0.010 GeneticVariation BEFREE These results suggest that the variants of MicroRNA SNPs, namely, rs2910164, rs11614913, and rs3746444, might be involved in susceptibility to ESRD and AR. 24978643

2014

dbSNP: rs11622435
rs11622435
0.700 GeneticVariation GWASCAT A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes. 29703844

2018

dbSNP: rs1162592300
rs1162592300
ALB
0.010 GeneticVariation BEFREE The -174G/C polymorphism of the IL-6 gene and the chemokine receptor CX3CR1 polymorphisms 249V/I and 280T/M were examined for their association with cardiovascular abnormalities in a cohort of 161 patients with end-stage renal disease (ESRD) treated by hemodialysis. 12846758

2003

dbSNP: rs11643718
rs11643718
0.010 GeneticVariation BEFREE The SLC12A3-Arg913Gln variation may be associated with increased blood pressure and UAER and, therefore, could be used to predict the development and progression of DN-ESRD in Chinese T2DM patients undergoing hemodialysis. 28744814

2018